1-(4-Bromophenyl)piperidin-2-one

Catalog No.: 
ACJSCB023
CAS No.: 
27471-43-8
Molecular Formula: 
C11H12BrNO
Molecular Weight: 
254.13
1-(4-Bromophenyl)piperidin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$54.00In stockIn stock
1g98%$111.00In stockIn stock
5g98%$351.00In stockIn stock
25g98%$1306.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Bromophenyl)piperidin-2-one
IUPAC Name1-(4-bromophenyl)piperidin-2-one
MDL No.0
Molecular FormulaC11H12BrNO
Molecular Weight254.13
SMILESO=C1N(C2=CC=C(Br)C=C2)CCCC1
InChI KeyRCYSBMQFKWYEBJ-UHFFFAOYSA-N
Synonym1-(4-BROMO-PHENYL)-PIPERIDIN-2-ONE;2-Piperidinone, 1-(4-bromophenyl)-;1-(4-Bromophenyl)-2-piperidinone
CAS No.27471-43-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACJSCB023 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHGDV157 route compound structure diagram
    ACHGDV157675-20-7In Stock
  4. Then
  5. ACJSCB023 route product structure diagram
    ACJSCB02327471-43-8In Stock
Inquiry

2. ACJSCB023 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKXSD380 route compound structure diagram
    ACKXSD380589-87-7In Stock
  2. Plus
  3. ACHGDV157 route compound structure diagram
    ACHGDV157675-20-7In Stock
  4. Then
  5. ACJSCB023 route product structure diagram
    ACJSCB02327471-43-8In Stock
Inquiry

3. ACJSCB023 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJSCB023 route product structure diagram
    ACJSCB02327471-43-8In Stock
Inquiry

Comments (0)